Minister Health and Director AIIMS statements not depict 100 % Q assured.
AIIMS director Randeep Guleria said India will use only Oxford-AstraZeneca vaccines in the first phase of Covid-19 vaccination and procure Bharat Biotech’s Covaxin only if the UK strain gets out of control of when the phase 3 trials are completed.
drharshvardhan· tweet Our experience with inactivated vaccines not having serious adverse events was also observed in Phase II done among 380 study participants in BBV152 trial in 21280 Person days follow up. No serious adverse events seen. Only 7% persons receiving 6 microgram dose had mild symptoms.
Covid 19 vaccines introduced in India will be as effective as developed by other countries: Govt
Government has said that the Covid-19 vaccines introduced in India will be as effective as any vaccine developed by other countries.
The Health Ministry has come out with a series of frequently asked questions about COVID-19 vaccine on various aspects. The Ministry said, various phases of vaccine trials are undertaken to ensure its safety and efficacy. In the initial phase Covid vaccine will be provided to the selected priority groups as they are at higher risk.
The first group who will be vaccinated includes healthcare and frontline workers. The second group to receive COVID 19 vaccine will be persons, over 50 years of age and persons under 50 years with comorbid conditions. The Ministry has said that vaccination for COVID-19 is voluntary. However, it has advised to receive the complete schedule of COVID-19 vaccine for protecting one-self against this disease. This will also limit the spread of this disease to the close contacts including family members, friends, relatives and co-workers.